Navigation Links
Flood of Fake Drugs Must Be Stopped, Warns UN

The International Narcotics Control Board (INCB) – an independent body that monitors the implementation of the United Nations drug control// standards – is calling for the danger of unregulated markets to be addressed on a priority basis.

In its annual report, the Vienna-based organisation called on member states to enforce legislation to ensure drugs are not illegally manufactured or diverted from authorised manufacture and distribution channels to unregulated markets.

The existence of unregulated markets means that second-rate medicines – which can be lethal – are sold to consumers.

"It is important for consumers to realise that what they think is a cut-price medication bought on an unregulated market may have potentially lethal effects whenever the consumed drugs are not the genuine product or are taken without medical advice," said Philip Emafo, president of the INCB.

"Instead of healing, they can take lives."

In some countries, up to 50 per cent of medicines are fakes, according to the World Health Organisation (WHO) and the growing counterfeit drug market is estimated to be worth a hefty $75bn (€57.3bn) globally by 2010.

The difficulty to monitor the spread of fake drugs is that counterfeit medicines are easy to manufacture – they look like genuine drugs in packaging and labelling.

According to the INCB report, another problem is the wide availability of controlled drugs – narcotics, benzodiazepines, amphetamines and other internationally controlled drugs are easily obtainable in many developing countries.

In addition, countries with weak regulations are most vulnerable to the marketing of counterfeit drugs. The INCP urged regulators to crack down on illegal pharmacies and the sale of medicines over the Internet.

"The problem of counterfeit medication and abuse of pharmaceuticals containing controlled substances bought without prescriptions has been in existence for some time," said Emafo.

"However, the rapid expansion of unregulated markets has dramatically worsened the situation."

Source-Bio-Bio TechnologySRM
'"/>




Related medicine news :

1. Epidemic Fear In Mumbai Mounting Post-Floods
2. Flood-ravaged Surat Issues Epidemic Warning
3. Songs Could Help to Overcome Flood Trauma
4. Flood Toll Rises, and Indonesia Braces for Disease
5. South-East Asia Flooded With Spurious Drugs
6. Lean Protein Could Be Key to Obesity Drugs
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. Nasal Spray Could Take Drugs Direct to Brain.
9. Emphasis to ban Drugs ads by Doctors
10. Osteoporosis Drugs: right time to take-off
11. Drugs disrupt formation of blood vessels
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... Olathe, KS (PRWEB) , ... April 28, 2017 ... ... system have typically been previously exposed to more adverse experiences than children in ... have experienced trauma such as abuse, neglect or other family challenges. While no ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... the Creator responds to and which He does not. Yisrayl says with so many ... is the true name, but he says with a little Scripture, backed with a lot ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that ... his presence to an educational purpose as the host of the “Informed” series. The ... In a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology: